News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Stacy Lindborg, PhD

Advertisement

Articles by Stacy Lindborg, PhD

IMUNON’s IMNN-101 Vaccine Shows Promising Results in Phase 1 Trial, Demonstrates Cross-Reactivity Against COVID Variants

BySophia Abene,Stacy Lindborg, PhD
March 7th 2025

Stacy Lindborg, PhD, highlights the vaccine’s immune response, safety, and global distribution potential.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Contagion Live

    1

    WHO Finds Progress in Malaria Prevention Measures

    2

    Once-Weekly Oral Islatravir Plus Lenacapavir Maintains HIV Suppression Through 48 Weeks

    3

    WHO Certifies Countries as Malaria Free in Face of Persistent Antimalarial Drug Resistance

    4

    CDC Awards Grant to Study Neonatal Hepatitis B Vaccination Outcomes in Guinea-Bissau

    5

    Optimism After Open-Label Study as Rising Carbapenem Resistance Shapes Future Treatment Guidance

    • About Us
    • Advertise
    • Editorial
    • Contact Us
    • Do Not Sell My Information
    • Privacy
    • Terms & Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us